Long-term outcome of giant cell tumor of bone involving sacroiliac joint treated with selective arterial embolization and curettage: A case report and literature review

7Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Giant cell tumor of the sacrum, especially involving the sacroiliac joint, is rare, but is particularly challenging to treat. The long term outcome of a patient was studied with giant cell tumor involving the sacroiliac joint treated with selective arterial embolization and curretage.Method: One patient with giant cell tumor involving the sacroiliac joint was treated with selective arterial embolization and curettage in our hospital in October 2002. The curettage and bone grafting was done after two times of selective arterial embolization;1600 ml of blood were transfused and no complications developed during the operation.Results: At the final follow-up of 9 years after the operation, no local recurrence and metastasis developed and she retained normal activity in daily life.Conclusion: We think it is an optimal treatment for giant cell tumor involving the sacroiliac joint, with repeated selective arterial embolization and curettage, which has the advantage of less injury, less blood loss and fewer complications. © 2013 Yu et al.; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Yu, X. C., Xu, M., Xu, S. F., & Fu, Z. H. (2013). Long-term outcome of giant cell tumor of bone involving sacroiliac joint treated with selective arterial embolization and curettage: A case report and literature review. World Journal of Surgical Oncology, 11. https://doi.org/10.1186/1477-7819-11-72

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free